Rh2 has demonstrated anti-tumor activity by inducing G1 cell cycle arrest, promoting differentiation, and facilitating apoptosis and autophagy through the downregulation of microRNA-638 in various cancer cell types [18,19,20]. The gene discussed is RHAG; the disease is neoplasm.